A retrospective study of 1064-nm Q-switched Nd:YAG laser therapy for acquired bilateral nevus of Ota-like macules
- PMID: 36973977
- PMCID: PMC10155852
- DOI: 10.1111/srt.13298
A retrospective study of 1064-nm Q-switched Nd:YAG laser therapy for acquired bilateral nevus of Ota-like macules
Abstract
Background: The therapeutic efficacy of laser treatments for acquired bilateral nevus of Ota-like macules (ABNOM) varies among studies, and few studies have evaluated the factors affecting therapeutic effects.
Aims: To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome.
Methods: A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The effects of different factors on the therapeutic effect were analyzed on the basis of the number of treatments, age at first treatment, skin type, lesion color, affected area, number of lesion sites, and presence of concomitant melasma.
Results: The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH).
Conclusions: Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
Keywords: 1064-nm Q-switched Nd:YAG laser; acquired bilateral nevus of Ota-like macules; melasma; postinflammatory hyperpigmentation; related factors.
© 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no relevant financial or nonfinancial interests to disclose.
Figures






Similar articles
-
Induction of melasma by 1064-nm Q-switched neodymium:yttrium-aluminum-garnet laser therapy for acquired bilateral nevus of Ota-like macules (Hori nevus): A study on related factors in the Chinese population.J Dermatol. 2016 Jun;43(6):655-61. doi: 10.1111/1346-8138.13193. Epub 2016 Jan 18. J Dermatol. 2016. PMID: 26777390
-
A retrospective study on the efficacy and complications of Q-switched alexandrite laser in the treatment of acquired bilateral nevus of Ota-like macules.Dermatol Surg. 2001 Nov;27(11):937-41; discussion 941-2. doi: 10.1046/j.1524-4725.2001.01094.x. Dermatol Surg. 2001. PMID: 11737127
-
A split-face, single-blinded, randomized controlled comparison of alexandrite 755-nm picosecond laser versus alexandrite 755-nm nanosecond laser in the treatment of acquired bilateral nevus of Ota-like macules.J Am Acad Dermatol. 2018 Sep;79(3):479-486. doi: 10.1016/j.jaad.2017.12.053. Epub 2017 Dec 27. J Am Acad Dermatol. 2018. PMID: 29288102 Clinical Trial.
-
A Retrospective Study of Picosecond Alexandrite Laser Treatment for Acquired Bilateral Nevus of Ota-Like Macules in Children.Lasers Surg Med. 2025 Jul;57(5):359-364. doi: 10.1002/lsm.70021. Epub 2025 Apr 29. Lasers Surg Med. 2025. PMID: 40302165 Review.
-
Optimizing Q-switched lasers for melasma and acquired dermal melanoses.Indian J Dermatol Venereol Leprol. 2019 Jan-Feb;85(1):10-17. doi: 10.4103/ijdvl.IJDVL_1086_16. Indian J Dermatol Venereol Leprol. 2019. PMID: 30027914 Review.
Cited by
-
Comparison of the Efficacy of 1064- and 730-nm Picosecond Lasers for Acquired Dermal Melanocytosis.J Cosmet Dermatol. 2025 Mar;24(3):e70123. doi: 10.1111/jocd.70123. J Cosmet Dermatol. 2025. PMID: 40087990 Free PMC article.
-
Comparison of the efficacy and safety of a 730-nm picosecond titanium sapphire laser and a 1064-nm picosecond neodymium yttrium aluminum garnet laser for the treatment of acquired bilateral nevus of Ota-like macules: A split-face, evaluator-blinded, randomized, and controlled pilot trial.J Cosmet Dermatol. 2024 Dec;23(12):3961-3967. doi: 10.1111/jocd.16511. Epub 2024 Aug 24. J Cosmet Dermatol. 2024. PMID: 39180331 Free PMC article. Clinical Trial.
-
Fractional and Non-Fractional Picosecond Nd:YAG Lasers Combined With Fractional Picosecond KTP Laser for the Treatment of Melasma in Female Chinese.Skin Res Technol. 2025 Aug;31(8):e70177. doi: 10.1111/srt.70177. Skin Res Technol. 2025. PMID: 40747731 Free PMC article.
-
Refractory solar lentigines successfully treated with 532-nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series.Skin Res Technol. 2024 Sep;30(9):e70055. doi: 10.1111/srt.70055. Skin Res Technol. 2024. PMID: 39300791 Free PMC article.
References
-
- Hori Y, Kawashima M, Oohara K, Kukita A. Acquired, bilateral nevus of Ota‐like macules. J Am Acad Dermatol. 1984;10(6):961‐964. - PubMed
-
- Sun C, Lü YC, Lee EF, Nakagawa H. Naevus fusco‐caeruleus zygomaticus. Br J Dermatol. 1987;117(5):545‐553. - PubMed
-
- Long T, Liu L, He Li, et al. Androgen, estrogen and progesterone receptors in acquired bilateral nevus of Ota‐like macules. Pigment Cell Melanoma Res. 2010;23(1):144‐146. - PubMed
-
- Kunachak S, Leelaudomlipi P, Sirikulchayanonta V. Q‐Switched ruby laser therapy of acquired bilateral nevus of Ota‐like macules. Dermatol Surg. 1999;25(12):938‐941. - PubMed
-
- Lam AY, Wong DS, Lam LK, Ho WS, Chan HH. A retrospective study on the efficacy and complications of Q‐switched alexandrite laser in the treatment of acquired bilateral nevus of Ota‐like macules. Dermatol Surg. 2001;27(11):937‐941. discussion 941–2. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical